4//SEC Filing
LA JOLLA PHARMACEUTICAL CO 4
Accession 0001209191-05-027436
CIK 0000920465operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:12 PM ET
Size
12.2 KB
Accession
0001209191-05-027436
Insider Transaction Report
Form 4
FILDES ROBERT PHD
Director
Transactions
- Award
Stock Option (right to buy)
2005-05-19$0.43/sh+10,000$4,300→ 120,732 totalExercise: $0.00From: 2006-05-19Exp: 2015-05-19→ Common Stock (10,000 underlying) - Award
Stock Option (right to buy)
2005-05-19$0.43/sh+50,000$21,500→ 170,732 totalExercise: $0.00Exp: 2015-05-19→ Common Stock (50,000 underlying)
Holdings
- 66,263
Common Stock
- 16,801(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The stock options vest and become exercisable monthly over the next three years. In the event there is a change in control of the Company, the options automatically vest as of the date of the change in control and remain exercisable for a period of one year following the date of the change in control.
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000920465
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 5:12 PM ET
- Size
- 12.2 KB